Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6076
Atara Biotherapeutics
ATRA
$94.2M
| $105K | ﹤0.01% |
9,178
+9
| +0.1% | +$72 |
2014 Q4
46 quarters
|
|
6077
Kestrel Group
KG
$36.9M
| $105K | ﹤0.01% |
11,664
-6,363
| -35% | -$70.6K |
2013 Q2
52 quarters
|
|
6078
Auburn National Bancorp
AUBN
$92.8M
| $105K | ﹤0.01% |
3,877
+1
| +0% | +$25 |
2020 Q2
24 quarters
|
|
6079
ProShares Pet Care ETF
PAWZ
$31.7M
| $104K | ﹤0.01% |
2,178
-132
| -6% | -$6.53K |
2020 Q3
23 quarters
|
|
6080
SES AI
SES
$297M
| $104K | ﹤0.01% |
108,608
-964,168
| -90% | -$1.05M |
2021 Q2
20 quarters
|
|
6081
VanEck International High Yield Bond ETF
IHY
$39.4M
| $104K | ﹤0.01% |
4,795
| – | – |
2013 Q2
52 quarters
|
|
6082
FT Vest US Equity Deep Buffer ETF April
DAPR
$331M
| $104K | ﹤0.01% |
+2,540
| New | +$103K |
2026 Q2
0 quarters
|
|
6083
Inspire Global Hope ETF
BLES
$164M
| $104K | ﹤0.01% |
2,176
+2,150
| +8,269% | +$102K |
2025 Q1
5 quarters
|
|
6084
FT Vest US Equity Buffer ETF December
FDEC
$1.34B
| $104K | ﹤0.01% |
1,904
| – | – |
2022 Q2
16 quarters
|
|
6085
Timothy Plan High Dividend Stock ETF
TPHD
$361M
| $104K | ﹤0.01% |
2,451
+1
| +0% | +$42 |
2024 Q3
7 quarters
|
|
6086
Airship AI Holdings
AISP
$84.7M
| $104K | ﹤0.01% |
43,336
-2,068
| -5% | -$5.28K |
2024 Q1
9 quarters
|
|
6087
iShares U.S. Carbon Transition Readiness Aware Active ETF
LCTU
$1.2B
| $104K | ﹤0.01% |
1,292
-973
| -43% | -$75.5K |
2021 Q2
20 quarters
|
|
6088
Geospace Technologies
GEOS
$59.6M
| $103K | ﹤0.01% |
15,255
-1,263
| -8% | -$10.9K |
2013 Q2
52 quarters
|
|
6089
STF Tactical Growth ETF
TUG
$35.1M
| $103K | ﹤0.01% |
2,170
| – | – |
2024 Q3
7 quarters
|
|
6090
Chicago Rivet & Machine Co
CVR
$10.6M
| $102K | ﹤0.01% |
9,844
+2,154
| +28% | +$22.4K |
2013 Q4
50 quarters
|
|
6091
Gadsden Dynamic Multi-Asset ETF
GDMA
$194M
| $102K | ﹤0.01% |
2,359
-300
| -11% | -$12.5K |
2024 Q3
7 quarters
|
|
6092
Bank Of The James
BOTJ
$123M
| $102K | ﹤0.01% |
4,010
-16
| -0.4% | -$372 |
2021 Q1
21 quarters
|
|
6093
JPMorgan International Value ETF
JIVE
$4.16B
| $102K | ﹤0.01% |
1,108
+61
| +6% | +$5.56K |
2024 Q4
6 quarters
|
|
6094
WisdomTree Dynamic International SmallCap Equity Fund
DDLS
$414M
| $101K | ﹤0.01% |
2,299
+1
| +0% | +$45 |
2022 Q4
14 quarters
|
|
6095
Innovator US Equity Power Buffer ETF January
PJAN
$1.43B
| $101K | ﹤0.01% |
2,044
| – | – |
2020 Q4
22 quarters
|
|
6096
Cartesian Therapeutics
RNAC
$211M
| $101K | ﹤0.01% |
9,687
-5,118
| -35% | -$37.9K |
2016 Q3
39 quarters
|
|
6097
Pyxis Oncology
PYXS
$168M
| $101K | ﹤0.01% |
33,448
-36,240
| -52% | -$69.3K |
2021 Q4
18 quarters
|
|
6098
Elicio Therapeutics
ELTX
$49.4M
| $99.9K | ﹤0.01% |
25,546
-6,858
| -21% | -$68.9K |
2021 Q1
21 quarters
|
|
6099
OnKure Therapeutics
OKUR
$98M
| $99.7K | ﹤0.01% |
21,858
+7,531
| +53% | +$32.3K |
2021 Q2
20 quarters
|
|
6100
American Century Focused Large Cap Value ETF
FLV
$378M
| $99.5K | ﹤0.01% |
1,224
+1
| +0.1% | +$80 |
2024 Q3
7 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.